Therapeutic cannabis: France has chosen its suppliers

By Laure Triquet-Maffeis / 27 January 2021 17 February 2021

Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

In this report, our objective was to optimize a method for the extraction of cannabinoids from a clone of Cannabis sativa L. #138 resulting from an agronomic test (LaFleur, Angers, …
Lire La Suite >

Article

Book “Medical Cannabis”

LaFleur publishes its book “Le Cannabis Médical” which proposes an enlightenment on the uses of medical cannabis as a central therapeutic and associates an adapted authorization regime …
Lire La Suite >

Article

Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair

DelleD and the Agrocampus Ouest Foundation have joined forces to create an “AgroHealth” corporate chair.In order to elaborate an efficient agronomic engineering, under controlled conditions, aiming at optimizing and standardizing …
Lire La Suite >

Press release

DelleD – LaFleur obtains a public funding of 500k€ for the development of its cannabis-based drug for the treatment of cancers refractory to available therapies

At a time when France needs to support the strategic health sector, DelleD announces that it has obtained €500k in funding for its research project on cancer treatment. LAFLEUR: A …
Lire La Suite >

Press release

Experimentation with cannabis for medical use

Call for tenders sprayers On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to …
Lire La Suite >

Press release

Follow us